Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations
Background/Objective Approximately 30% of patients with MDS eventually develop to acute myeloid leukemia (AML). Our study aimed to investigate the mutation landscape of Chinese MDS patients and identify the mutated genes which are closely implicated in the transformation of MDS to AML.Methods In tot...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2392469 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850246552490082304 |
|---|---|
| author | Yu Liu Huanchen Cheng Mei Cheng Meng Sun Jun Ma Tiejun Gong |
| author_facet | Yu Liu Huanchen Cheng Mei Cheng Meng Sun Jun Ma Tiejun Gong |
| author_sort | Yu Liu |
| collection | DOAJ |
| description | Background/Objective Approximately 30% of patients with MDS eventually develop to acute myeloid leukemia (AML). Our study aimed to investigate the mutation landscape of Chinese MDS patients and identify the mutated genes which are closely implicated in the transformation of MDS to AML.Methods In total, 412 sequencing data collected from 313 patients were used for analysis. Mutation frequencies between different groups were compared by Fisher's exact. A predictive model for risk of transformation/death of newly diagnosed patients was constructed by logistic regression.Results The most frequently mutated genes in newly diagnosed patients were TP53, TET2, RUNX1, PIGA, and BCOR and mutations of RUNX1, TP53, BCORL1, TET2, and BCOR genes were more common in the treated MDS patients. Besides, we found that the mutation frequencies of IDH2, TET2, and EZH2 were significantly higher in MDS patients aged over 60 years. Moreover, two mutation sites, KRASG12A and TP53H140N were detected only at transformation in one patient, while not detected at diagnosis. In addition, the mutation frequencies of EZH2 V704F and TET2 I1873N were stable from diagnosis to transformation in two patients. Finally, we constructed a predictive model for risk of transformation/death of newly diagnosed patients combing detected data of 10 genes and the number of to leukocyte, with a sensitivity of 63.3% and a specificity of 84.6% in distinguishing individuals with and without risk of transformation/death.Conclusion In summary, our study found several mutations associated with the transformation from MDS to AML, and constructed a predictive model for risk of transformation/death of MDS patients. |
| format | Article |
| id | doaj-art-e2a8ab2bc3a542f6ad27717daf9c2ea0 |
| institution | OA Journals |
| issn | 1607-8454 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Hematology |
| spelling | doaj-art-e2a8ab2bc3a542f6ad27717daf9c2ea02025-08-20T01:59:10ZengTaylor & Francis GroupHematology1607-84542024-12-0129110.1080/16078454.2024.2392469Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformationsYu Liu0Huanchen Cheng1Mei Cheng2Meng Sun3Jun Ma4Tiejun Gong5Institute of Harbin Hematology and Oncology, the first hospital of Harbin, Harbin, People’s Republic of ChinaInstitute of Harbin Hematology and Oncology, the first hospital of Harbin, Harbin, People’s Republic of ChinaInstitute of Harbin Hematology and Oncology, the first hospital of Harbin, Harbin, People’s Republic of ChinaInstitute of Harbin Hematology and Oncology, the first hospital of Harbin, Harbin, People’s Republic of ChinaInstitute of Harbin Hematology and Oncology, the first hospital of Harbin, Harbin, People’s Republic of ChinaInstitute of Harbin Hematology and Oncology, the first hospital of Harbin, Harbin, People’s Republic of ChinaBackground/Objective Approximately 30% of patients with MDS eventually develop to acute myeloid leukemia (AML). Our study aimed to investigate the mutation landscape of Chinese MDS patients and identify the mutated genes which are closely implicated in the transformation of MDS to AML.Methods In total, 412 sequencing data collected from 313 patients were used for analysis. Mutation frequencies between different groups were compared by Fisher's exact. A predictive model for risk of transformation/death of newly diagnosed patients was constructed by logistic regression.Results The most frequently mutated genes in newly diagnosed patients were TP53, TET2, RUNX1, PIGA, and BCOR and mutations of RUNX1, TP53, BCORL1, TET2, and BCOR genes were more common in the treated MDS patients. Besides, we found that the mutation frequencies of IDH2, TET2, and EZH2 were significantly higher in MDS patients aged over 60 years. Moreover, two mutation sites, KRASG12A and TP53H140N were detected only at transformation in one patient, while not detected at diagnosis. In addition, the mutation frequencies of EZH2 V704F and TET2 I1873N were stable from diagnosis to transformation in two patients. Finally, we constructed a predictive model for risk of transformation/death of newly diagnosed patients combing detected data of 10 genes and the number of to leukocyte, with a sensitivity of 63.3% and a specificity of 84.6% in distinguishing individuals with and without risk of transformation/death.Conclusion In summary, our study found several mutations associated with the transformation from MDS to AML, and constructed a predictive model for risk of transformation/death of MDS patients.https://www.tandfonline.com/doi/10.1080/16078454.2024.2392469Myelodysplastic syndromestransformationacute myeloid leukemiamutationpredictive model |
| spellingShingle | Yu Liu Huanchen Cheng Mei Cheng Meng Sun Jun Ma Tiejun Gong Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations Hematology Myelodysplastic syndromes transformation acute myeloid leukemia mutation predictive model |
| title | Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations |
| title_full | Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations |
| title_fullStr | Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations |
| title_full_unstemmed | Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations |
| title_short | Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations |
| title_sort | next generation sequencing reveals the mutation landscape of chinese mds patients and the association between mutations and aml transformations |
| topic | Myelodysplastic syndromes transformation acute myeloid leukemia mutation predictive model |
| url | https://www.tandfonline.com/doi/10.1080/16078454.2024.2392469 |
| work_keys_str_mv | AT yuliu nextgenerationsequencingrevealsthemutationlandscapeofchinesemdspatientsandtheassociationbetweenmutationsandamltransformations AT huanchencheng nextgenerationsequencingrevealsthemutationlandscapeofchinesemdspatientsandtheassociationbetweenmutationsandamltransformations AT meicheng nextgenerationsequencingrevealsthemutationlandscapeofchinesemdspatientsandtheassociationbetweenmutationsandamltransformations AT mengsun nextgenerationsequencingrevealsthemutationlandscapeofchinesemdspatientsandtheassociationbetweenmutationsandamltransformations AT junma nextgenerationsequencingrevealsthemutationlandscapeofchinesemdspatientsandtheassociationbetweenmutationsandamltransformations AT tiejungong nextgenerationsequencingrevealsthemutationlandscapeofchinesemdspatientsandtheassociationbetweenmutationsandamltransformations |